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Abstract 1 
In a previous study, the drinking of a Salvia officinalis tea (prepared as an 2 
infusion) for 14 days improved liver antioxidant status in mice and rats where, among 3 
other factors, an enhancement of glutathione-S-transferase (GST) activity was observed. 4 
Taking in consideration these effects, in the present study the potential protective effects 5 
of sage tea drinking against a situation of hepatotoxicity due to free radical formation, 6 
such as that caused by carbon tetrachloride (CCl4), were evaluated in mice of both 7 
genders. Contrary to what was expected, sage tea drinking significantly increased the 8 
CCl4-induced liver injury, as seen by increased plasma transaminase levels and 9 
histology liver damage. In accordance with the previous study, sage tea drinking 10 
enhanced significantly GST activity. Additionally, glutathione peroxidase was also 11 
significantly increased by sage tea drinking. Since CCl4 toxicity results from its 12 
bioactivation mainly by cytochrome P450 (CYP) 2E1, the expression level of this 13 
protein was measured by Western Blot. An increase in CYP 2E1 protein was observed 14 
which may explain, at least in part, the potentiation of CCl4-induced hepatotoxicity 15 
conferred by sage tea drinking. The CCl4-induced hepatotoxicity was higher in females 16 
than males. In conclusion, our results indicate that, although sage tea did not have toxic 17 
effects of its own, herb-drug interactions are possible and may affect the efficacy and 18 
safety of concurrent medical therapy with drugs that are metabolized by phase I 19 
enzymes.20 
3 
1. Introduction 21 
Chronic liver diseases are common worldwide and are characterized by a 22 
progressive evolution from steatosis to chronic hepatitis, fibrosis, cirrhosis, and 23 
hepatocellular carcinoma (Loguercio and Federico, 2003; Vitaglione et al., 2004). There 24 
are increasing evidences that free radicals and reactive oxygen species play a crucial 25 
role in the various steps that initiate and regulate the progression of liver diseases 26 
independently of the agent in its origin (Loguercio and Federico, 2003; Vitaglione et al., 27 
2004). By virtue of its unique vascular and metabolic features, the liver is exposed to 28 
absorbed drugs and xenobiotics in concentrated form. Detoxification reactions (phase I 29 
and phase II) metabolize xenobiotics aiming to increase substrate hydrophilicity for 30 
excretion. Drug-metabolizing enzymes detoxify many xenobiotics but bioactivate or 31 
increase the toxicity of others (Jaeschke et al., 2002). In case of bioactivation, the liver 32 
is the first organ exposed to the damaging effects of the newly formed toxic substance. 33 
Therefore, protective mechanisms relevant to the liver are of particular interest. 34 
Because free radicals and reactive oxygen species play a central role in liver 35 
diseases pathology and progression, dietary antioxidants have been proposed as 36 
therapeutic agents to counteract liver damage (Vitaglione et al., 2004). Additionally, 37 
recent studies have suggested that natural antioxidants in complex mixtures ingested 38 
with the diet are more efficacious than pure compounds in preventing oxidative stress-39 
related pathologies due to particular interactions and synergisms (Vitaglione et al., 40 
2004). Natural antioxidants may act as protectors of several pathologies not only as 41 
conventional hydrogen-donating compounds (antiradical activity) but, more 42 
importantly, may exert modulatory effects in cells through actions in antioxidant, drug-43 
metabolizing and repairing enzymes as well as working as signaling molecules in 44 
important cascades for cell survival (Ferguson et al., 2004; Williams et al., 2004). 45 
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Salvia officinalis L. (common sage) is a medicinal plant well known for its 46 
reputation of being a panacea and for its strong antioxidant properties attributed to its 47 
constitution in phenolic compounds (rosmarinic acid being the most representative) 48 
(Cuvelier et al., 1994; Baricevic and Bartol, 2000). In an in vivo study using rats, 49 
treatment with a sage water extract for 5 weeks protected against the hepatotoxicity of 50 
azathioprine, a drug that acts by reducing GSH levels, revealing the antioxidant 51 
properties of this extract (Amin and Hamza, 2005). Drinking of sage tea (prepared as an 52 
infusion) for 14 days also improved liver antioxidant status in mice and rats. It 53 
significantly increased the activity of a phase II detoxifying enzyme, glutathione-S-54 
transferase (GST), and protected against lipid peroxidation and GSH depletion induced 55 
by an oxidant insult (tert-butyl hydroperoxide) in rat hepatocytes in primary culture 56 
(Lima et al., 2005). In view of these observations we hypothesised that sage tea would 57 
have protective effects in an in vivo situation of free radical-mediated hepatotoxicity, 58 
such as that caused by the well known hepatotoxin carbon tetrachloride (CCl4). 59 
Therefore, in the present study, we evaluate the potential hepatoprotective effects of 60 
sage tea drinking for 14 days against a subsequent acute toxic dose of CCl4 in mice. 61 
In the liver, CCl4 metabolism begins with the formation of the trichloromethyl 62 
radical (CCl3˙) through the action of cytochrome P450 (CYP) enzymes, phase I drug-63 
metabolizing or detoxifying enzymes. This radical can also react with oxygen to form 64 
its highly reactive derivative trichloromethylperoxy radical (CCl3OO˙). Both radicals 65 
initiate chain reactions of direct and indirect bond formation with cellular molecules 66 
(nucleic acids, proteins, lipids and carbohydrates) impairing crucial cellular processes 67 
that may ultimately culminate in extensive cell damage and death (Weber et al., 2003). 68 
The bioactivation of CCl4 is mainly executed by the CYP 2E1 isozyme, but at higher 69 
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concentrations CYP 2B1, CYP 2B2 and CYP 3A (only in humans) are capable of 70 
attacking this haloalkane (Weber et al., 2003). 71 
Because the bioactivation of the drug needs to occur in this model of 72 
hepatotoxicity, effects on the activity of CYP enzymes and in particular the expression 73 
of CYP 2E1 should be considered when studying effects on CCl4 toxicity. It is well 74 
known today that the inhibition of CYP 2E1 decreases CCl4 hepatotoxicity. On the 75 
other hand, the induction of this cytochrome increases the drug’s hepatotoxicity (Weber 76 
et al., 2003). Since pharmaceutical drugs may also be metabolized by CYP enzymes, 77 
drug-drug interactions are possible and have been recognized between herbal medicines 78 
and conventional drugs, which may affect the safety of phytomedicine users (Ioannides, 79 
2002; Izzo, 2005; Hu et al., 2005).  80 
Finally, gender is another factor that should be studied. Because CYP enzyme 81 
activities are known to be gender dependent (Kato and Yamazoe, 1992; Clewell et al., 82 
2002; Meibohm et al., 2002), the extension of cell damage caused by toxicants that are 83 
metabolized by phase I enzymes may be significantly different in males and females. 84 
We therefore evaluated the gender effect on the potential protection against CCl4-85 
induced hepatotoxicity conferred by sage tea drinking in mice. 86 
 87 
2. Materials and methods 88 
2.1. Chemicals 89 
Glutathione reductase (EC 1.6.4.2.), glucose-6-phosphate dehydrogenase (EC 90 
1.1.1.49.), aprotinine, tert-butyl hydroperoxide (t-BHP), 7-ethoxyresorufin, 7-91 
pentoxyresorufin and Bradford reagent were purchased from Sigma (St. Louis, MO, 92 
USA). The rabbit polyclonal antibody against CYP 2E1 protein was purchased from 93 
StressGen (Victoria, Canada). All other reagents were of analytical grade. 94 
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2.2. Plant material, preparation of sage tea and composition in phenolic and volatile 96 
compounds 97 
Salvia officinalis L. plants were cultivated in an experimental farm located in 98 
Arouca, Portugal, and were collected in April, 2001. The aerial parts of plants were 99 
lyophilized and kept at -20 ºC. Considering that sage is traditionally used as a tea, an 100 
infusion of sage was routinely prepared as in a previous study by pouring 150 ml of 101 
boiling water onto 2 g of the dried plant material and allowing to steep for 5 min (Lima 102 
et al., 2005). This preparation produced a 3.5 ± 0.1 mg of dry weight extract per ml of 103 
infusion, with rosmarinic acid (362 µg/ml of infusion) and luteolin-7-glucoside (115.3 104 
µg/ml of infusion) as a major phenolic compounds and 1,8-cineole, cis-thujone, trans-105 
thujone, camphor and borneol as major volatile compounds (4.8 µg/ml of infusion) 106 
(Lima et al., 2005). 107 
 108 
2.3. Animals 109 
 Twenty male and twenty female Balb/c mice, 6-8 weeks (male: 20.3 ±  2.4; 110 
female: 17.6 ± 1.9), were purchased from Charles River Laboratories (Spain) and 111 
acclimated to our laboratory animal facilities for at least one week before the start of the 112 
experiments. During this period, the animals were maintained on a natural light/dark 113 
cycle at 20 ± 2 ºC and given food and tap water ad libitum. The animals used in this 114 
experiment were kept and handled in accordance to our University regulations that 115 
follows the Guidelines for the Humane Use and Care of Laboratory Animals. 116 
 117 
2.4. CCl4-induced hepatotoxicity in mice 118 
7 
Twenty male Balb/c mice were randomly divided into two groups (five per 119 
cage), given food ad libitum and either drinking water (tap) or sage tea ad libitum for 14 120 
days (beverage was renewed daily). Twenty four hours before the end of the 121 
experiment, half the animals of each drinking group received an ip injection of CCl4 in 122 
order to observe the hepatic injury effects (Chung et al., 2005). CCl4 was administered 123 
ip at 20 µl/kg in olive oil (8 ml/kg) to induce liver injury as previously described (Chen 124 
et al., 2004), and controls received vehicle only. At the end of the experiment, animals 125 
were sacrificed by cervical dislocation and plasma collected for measurement of 126 
transaminase activities (ALT-alanine aminotransferase and AST-aspartate 127 
aminotransferase). The livers were also collected, frozen in liquid nitrogen and kept at -128 
80 ºC for later analysis and measurement of several liver parameters. 129 
The same experimental outline was used for the twenty female Balb/c mice. 130 
 131 
2.5. Biochemical analysis 132 
Histological examinations 133 
 A fresh piece of the liver from each mouse, previously trimmed to 134 
approximately 2 mm thickness, was rapidly immersed in Bouin’s solutionand kept for 135 
24 h at 4 ºC. Fixed tissues were then processed routinely for embedding in paraffin, 136 
sectioned (5 µm), deparaffinized and rehydrated using standard techniques. The extent 137 
of CCl4-induced liver damage was evaluated based on morphological changes in liver 138 
sections stained with hematoxylin and eosin (H&E) using standard techniques. 139 
Histological damage was expressed using the following score system: 0 - absent; + - 140 
few; + + - mild; + + + - moderate; + + + + - severe; and, + + + + + - extremely severe. 141 
Liver homogenates and microsome isolation 142 
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For measurement of the activities of GST, glutathione peroxidase (GPox), 143 
glutathione reductase (GR) and NADPH-cytochrome P450 reductase (CYPR) in mice 144 
liver, a piece of tissue was homogenized individually in a phosphate/glycerol buffer pH 145 
7.4 (Na2HPO4 20 mM; β-mercaptoethanol 5 mM; EDTA 0.5 mM; BSA 0.2% (w/v); 146 
aprotinine 10µg/ml and glycerol 50% (v/v)) and centrifuged at 10,000 × g at 4 ºC for 10 147 
min and the supernatant collected.  148 
 For measurement of the activities of cytochromes P450 and analysis of the 149 
expression level of CYP 2E1 protein, liver microsomes were isolated by differential 150 
centrifugation as described elsewhere (Barbier et al., 2000). In brief, a piece of the liver 151 
was homogenized in homogenization buffer (80 mM K2HPO4, 80 mM KH2PO4 (pH 152 
7.4), 20% (v/v) glycerol, 1 mM EDTA, 1 mM dithiothreitol and 0.1 mM  153 
phenylmethanesulfonyl fluoride) and centrifuged at 12,000 × g at 4 ºC for 20 min. The 154 
supernatant was collected and centrifuged at 105,000 × g at 4 ºC for 1 h. Microsomal 155 
pellets were resuspended in homogenization buffer, rapidly frozen in liquid nitrogen 156 
and stored at -80 ºC. 157 
 Enzyme activities 158 
Alanine aminotransferase (ALT), aspartate aminotransferase (AST), GST and 159 
GR activities were measured spectrophotometrically as previously described (Lima et 160 
al., 2005). GPox activity was also measured as previously described by Lima et al. 161 
(2006). 162 
The CYPR activity was determined indirectly by measuring its NADPH-163 
cytochrome c reductase activity as previously described (Phillips and Langdon, 1962) 164 
with the modifications introduced by Plaa and Hewitt (1982) and the results expressed 165 
as nmol cytochrome c reduced per minute per mg of protein (mU/mg). 166 
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Microsomal ethoxyresorufin-O-dealkylation (EROD) and pentoxyresorufin-O-167 
dealkylation (PROD) were determined according to Burke et al. (1985) with some 168 
modifications (Pearce et al., 1996). Briefly, liver microsomes (0.2 mg) were incubated 169 
at 37 ºC in 1 ml (final volume) incubation mixture containing 100 mM KH2PO4 (pH 170 
7.4), 7.5 mM MgCl2, 1 mM EDTA, 0.5 mM NADP – 5 mM glucose-6-phosphate/0.5 171 
U/ml glucose-6-phosphate dehydrogenase and either 7-ethoxyresorufin (5 µM) or 7-172 
pentoxyresorufin (10 µM) in the EROD or PROD activities, respectively. Reactions 173 
were started by addition of the NADPH-generating system and were stopped after 5 min 174 
by addition of 2 ml of ice-cold acetone. After centrifugation, the amount of resorufin 175 
was determined fluorometrically with a Perkin Elmer LS50 spectrophotometer (Perkin-176 
Elmer Ltd., Buckinghamshire, UK). The activity was expressed as pmol resorufin 177 
formed/min/mg microsomal proteins using a standard curve of resorufin. 178 
 Paranitrophenol hydroxylation (PNP-H) in liver microsomes was assessed 179 
according to the methodology previously described by Allis and Robinson (1994), 180 
following specrophotometrically at 480 nm the formation 4-nitrocatechol. Briefly, 0.2 181 
mg of microsomal proteins were pre-incubated for 5 min at 37 ºC with 1 mM p-182 
nitrophenol and 100 mM Hepes (pH 6.8). Five minutes after adding the NADPH-183 
generating system, the formation of 4-nitrocatechol was followed at 480 nm at 37 ºC on 184 
a plate reader spectrophotometer and the results expressed as pmol 4-nitrocatechol 185 
formed/min/mg microsomal proteins using the extinction coefficient of 3.567 mM-1.cm-186 
1. 187 
Glutathione content 188 
The glutathione content of mice livers was determined by the DTNB-GSSG 189 
reductase recycling assay as previously described (Lima et al., 2004). The results are 190 
expressed as nmol GSH/mg of liver. 191 
10 
Protein 192 
Protein content of liver homogenates was determined with Bradford Reagent 193 
using bovine serum albumin as a standard. Protein content of liver microsomes was 194 
determined by the Lowry method (Lowry et al., 1951). 195 
 196 
2.6. CYP 2E1 expression analysis 197 
 The expression of CYP 2E1 protein was analyzed by Western Blot. 198 
Electrophoretic separation of microsomal proteins (15 µg) was performed in 12% 199 
sodium dodecyl sulfate–polyacrylamide gels (SDS–PAGE) using the mini-PROTEAN 3 200 
electrophoresis cell (Bio-Rad Laboratories, Inc., Hercules, California, USA) according 201 
to the method of Laemmli (1970). The separated proteins were electrotransferred to 202 
polyvinylidene difluoride (PVDF) membranes (Amersham Biosciences, 203 
Buckinghamshire, UK) using the method of Towbin and collaborators (1979). The 204 
PVDF membranes were blocked with 5% nonfat dry milk overnight at 4°C and the 205 
immunoblots exposed to rabbit polyclonal antibody against CYP 2E1 protein. 206 
Immunodetection was performed using horseradish peroxidase–labeled donkey anti-207 
rabbit IgG antibody (Amersham Biosciences, Buckinghamshire, UK) and developed 208 
with ECL reagents (Amersham Biosciences) according to manufacturer’s instructions. 209 
The amount of protein was quantified by densitometry analysis on the SigmaScan Pro 5 210 
program (SPSS Inc., San Rafael, CA, USA) and expressed as percentage of the protein 211 
level present in control situation. 212 
 213 
2.7. Statistical Analysis 214 
Data are expressed as means ± SEM (n=5). Statistical significances (P values < 215 
0.05) were evaluated by two-way ANOVA based on gender and treatment group (water 216 
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drinking + saline ip; water drinking + CCl4 ip; sage tea drinking + saline ip; sage tea 217 
drinking + CCl4 ip) followed by the Student-Newman-Keuls post hoc test. ALT and 218 
AST data were natural logarithm transformed prior to statistical analysis in order to 219 
stabilize the variance. 220 
 221 
3. Results 222 
 The effect of drinking of sage tea for 14 days (instead of water) on the 223 
hepatotoxicity of CCl4 was evaluated in mice of both genders challenged with a single 224 
dose of CCl4 (20 µl/kg, ip). Plasma transaminase activities were measured 24 h after 225 
CCl4 administration as markers of liver injury (Fig. 1). Elevated ALT and AST activities 226 
were observed due to CCl4 administration, which is always higher in females compared 227 
with males. Both males and females that had been drinking sage tea were significantly 228 
more sensitive to the hepatotoxic effects of CCl4 than their control counterparts, as 229 
indicated by increased plasma transaminase activities. 230 
 CCl4 is a hepatotoxicant known to produce a characteristic centrilobular pattern 231 
of degeneration and necrosis (Weber et al., 2003). Histological examination of H&E-232 
stained liver sections was conducted 24 h after CCl4 administration to confirm the 233 
pattern of hepatotoxicity and compare the extent of liver injury between control and 234 
sage tea drinking animals (Table 1). Morphological findings were consistent with 235 
plasma transaminase observations. The CCl4 induced histopathological changes in the 236 
liver with significant degeneration and necrosis of hepatocytes in the centrilobular 237 
region and with perivenular inflammatory infiltrates. These CCl4-induced 238 
histopathological changes were significantly potentiated in the sage tea drinking group 239 
of mice with about 50-60% of total area presenting signs of degeneration, necrotic 240 
<Insert 
figure 1 
here> 
<Insert 
table 1 
here> 
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regions and higher leukocyte infiltration. Also histologically, the liver damage induced 241 
by the CCl4 in mice appear to be higher in females than in males. 242 
 CCl4 is a hepatotoxic chemical that requires metabolic activation by phase I 243 
drug-metabolizing enzymes and therefore it was important to monitor the effects of sage 244 
tea drinking on the activity of some CYP enzymes. For that, EROD, PROD and PNP-H 245 
were measured in liver microsomal fractions (Table 2). Comparing the groups where 246 
CCl4 was not administered, although not statistically significant, sage tea drinking 247 
increased slightly, between 8% and 13%, the activity of CYP 1A and CYP 2E1 in both 248 
genders. The activities of CYP 2B and CYP 2E1 in females was lower and higher, 249 
respectively, when compared with males. Twenty four hours after administration, CCl4 250 
hepatotoxicity was also reflected in the decrease observed for the activities of the CYP’s 251 
measured as well as in the majority of the others enzyme activities (Table 3). 252 
Comparing drinking groups, the decrease in these enzyme activities after CCl4 253 
administration was also consistent with the higher toxicity in sage tea groups, since it 254 
was in general significantly higher in sage tea than water drinking mice. 255 
 The CYPR is an essential enzyme for microssomal P450-mediated 256 
monooxygenase activity, which by interaction with the different CYP’s transfers the 257 
essential electron from NADPH (Backes and Kelley, 2003; Henderson et al., 2003). 258 
Therefore, its activity was measured (Table 2), and was found to be significantly higher 259 
in female mice, which indirectly may contributed to higher toxicity of CCl4 in females. 260 
Sage tea drinking induced 21% the activity of this cytochrome, but only in female mice. 261 
 The bioactivation of CCl4 is mainly executed by CYP 2E1 (Weber et al., 2003). 262 
It is also known that modulatory effects on the expression of CYP 2E1 affects the CCl4-263 
induced hepatotoxicity (Weber et al., 2003). Therefore, in addition to the measurement 264 
of some CYP enzyme activities which included the CYP 2E1, the expression of this 265 
<Insert 
table 2 
here> 
<Insert 
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cytochrome was evaluated by Western Blot (Fig. 2). Sage tea drinking for 14 days 266 
increased significantly the amount of CYP 2E1 protein in females (24%) abut it only 267 
slightly increased in males (8%). In sage tea drinking mice, the decrease on CYP 2E1 268 
protein induced by CCl4 was most severe in females. 269 
 After bioactivation, CCl4-induced hepatotoxicity is mediated by primary and 270 
secondary bond formation of reactive species to critical cellular molecules such as 271 
DNA, lipids, proteins or carbohydrates (Weber et al., 2003). Thus, detoxifying enzymes 272 
(such as GST) and antioxidant enzymes (such as the pair GPox/GR) are important 273 
against the cell stress situation caused by CCl4. To monitor effects at this level, three 274 
glutathione-related enzymes were measured (Table 3) and gender differences were 275 
observed in all of them. The activity of GST in males was significantly increased by 276 
sage tea drinking, as previously observed in other study (Lima et al., 2005). GPox 277 
activity was also increased by sage tea drinking but significantly only in females. 278 
Hepatic GSH is an important intracellular antioxidant that can scavenge free radicals 279 
and could be important in the defense against radical-mediated hepatotoxicity. 280 
Alterations in GSH and oxidized glutathione (GSSG) levels are therefore an important 281 
indicator of oxidative stress. Comparing the groups where CCl4 was not administered, 282 
there was no effect of sage tea drinking on GSH and GSSG levels in male and female 283 
mice (Table 3). Twenty four hours after CCl4 administration, GSH levels decreased 284 
significantly only in females from the sage tea drinking group. GSSG levels increased 285 
significantly after CCl4 administration in both genders but only in the sage tea drinking 286 
groups (Table 3). This increase was significantly higher in females than males. As a 287 
result, glutathione data also suggest higher cell damage induced by CCl4 in the sage tea 288 
drinking groups in females.  289 
<Insert 
figure 2 
here> 
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Finally, soluble protein measured after 10,000 × g centrifugation (Table 3) 290 
corroborates the previous results. Comparing the groups where CCl4 was not 291 
administered, the higher soluble protein found in the sage tea drinking groups suggests 292 
induction of protein expression. The decrease in soluble protein, with concomitant 293 
precipitation of damaged proteins, found after the haloalkane administration suggests 294 
higher toxicity of CCl4 in the sage tea drinking groups and in females. 295 
 296 
4. Discussion 297 
 In a previous study, sage tea drinking significantly increased (rat and mouse) 298 
liver GST activity and protected against GSH depletion and lipid peroxidation induced 299 
by an oxidant agent (Lima et al., 2005). Considering these beneficial effects on liver 300 
antioxidant status the present study was carried out in order to evaluate whether sage tea 301 
drinking would reduce the extent of hepatic injury induced by CCl4 in male and female 302 
mice. In a recently published work, GST was implicated as an important defence 303 
mechanism during the early stages (1–6 h) of the CCl4-induced liver injury (Dwivedi et 304 
al., 2006). GST is a phase II enzyme that plays a key role in cellular detoxification of 305 
xenobiotics, electrophiles and reactive oxygen species through their conjugation to GSH 306 
(Mates, 2000). Besides an essential substrate to GST and GPox, GSH is also an 307 
important intracellular antioxidant (hydrogen-donating compound) that spontaneously 308 
neutralizes several electrophiles and reactive oxygen species (Lu, 1999). After 309 
bioactivation of CCl4, in addition to dangerous free radical formation and subsequent 310 
reactive oxygen species formation, a sequence of chain reactions can be initiated that 311 
leads to lipid peroxidation (Weber et al., 2003). Since sage tea drinking has also been 312 
shown to decrease lipid peroxidation induced by tert-butyl hydroxide in rat hepatocyte 313 
primary cultures (Lima et al, 2005), this also suggested here possible beneficial effects 314 
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against CCl4. However, contrary to our hypothesis, sage tea drinking increased 315 
significantly the CCl4-induced hepatotoxicity in mice. 316 
CCl4 becomes toxic upon activation mainly through CYP 2E1, and an induction 317 
or an over-expression of this cytochrome correlates with higher CCl4 toxicity (Weber et 318 
al., 2003; Chan et al., 2005). Sage tea drinking for 14 days increased the expression 319 
level of CYP 2E1. In agreement with this, the activity of this cytochrome was also 320 
slightly increased by sage tea drinking. This could provide an explanation for the higher 321 
CCl4 toxicity in tea drinking mice. CYP 2E1 protein is localized predominantly in the 322 
central zone of the liver lobule (Forkert et al., 1991), which explains the typical 323 
centrilobular region of hepatocyte injury observed after CCl4 administration. This 324 
pattern of centrilobular toxicity was more extensive in sage tea versus water drinking 325 
mice. After CCl4 bioactivation, the resulting CCl3˙ radical binds covalently to CYP 2E1, 326 
either to the active site of the enzyme or to the heme group, thereby causing suicide 327 
inactivation (Weber et al., 2003). After drug administration to sage tea drinking mice, 328 
CYP 2E1 levels, originally higher, decreased to significant lower levels. A decrease in 329 
CYP 2E1 expression and activity after CCl4 exposure seem to reflect inactivation of the 330 
protein, which is consistent with the increased CCl4 hepatotoxicity in this drinking 331 
group. However, to confirm increased CCl4 bioactivation through CYP 2E1 in sage tea 332 
drinking mice than the water drinking cohorts, measurement of covalent binding of 333 
14CCl4-derived radiolabel to liver tissue would have to be done. The simultaneous 334 
increases in GST and GPox activities by sage tea drinking, and possibly other 335 
detoxifying and antioxidant enzymes, seem to have been incapable of neutralizing 336 
increased CCl4 toxicity. Also, the previously observed beneficial effect of sage tea 337 
against lipid peroxidation (Lima et al., 2005) seemed to be insufficient to block CCl4-338 
induced damage. The increased levels of CYP 2E1 protein and activity induced by sage 339 
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tea drinking may, thus, at least in part, provide an explanation for the obtained results – 340 
an herb-toxicant interaction between sage tea and CCl4 that potentiated the haloalkane’s 341 
toxicity. 342 
Herb-drug interactions have been described for a variety of plants used as 343 
phytomedicines, many of them by case reports of interactions between herbs and 344 
pharmaceutical drugs (Izzo, 2005; Hu et al., 2005). CYP isozymes are particularly 345 
vulnerable to modulation by the diverse active constituents of herbs (Zhou et al., 2003). 346 
This important phase I drug-metabolizing enzyme system is responsible for the 347 
metabolism of a variety of xenobiotics and some important endogenous substances such 348 
as steroids and prostaglandins (Anzenbacher and Anzenbacherova, 2001; Tamasi et al., 349 
2003). Although CYP-mediated reactions are primarily detoxification processes, certain 350 
substrates are metabolically activated resulting in the generation of reactive 351 
intermediates with increased toxicity and mutagenicity (Jaeschke et al., 2002; Tamasi et 352 
al., 2003). Many pharmaceutical drugs are also metabolized by these phase I enzymes 353 
and modulation of CYPs by herbs may either exacerbate the undesirable effects (by 354 
increasing toxicity) or antagonize the actions (by increasing clearance) of concurrent 355 
medical therapy (Stedman, 2002). In addition, severe hepatic injury may be caused by 356 
chemicals or natural toxins metabolically activated by drug-metabolizing enzymes as a 357 
result of occupational, household or environmental exposure, emphasizing the need for 358 
understanding mechanisms of action of herbal extracts. Thus, although interspecies 359 
differences in xenobiotic metabolism are well documented (Caldwell, 1992), the drug-360 
toxicant interaction between sage tea and CCl4 reported here highlight possible herb-361 
drug interactions between this extract and drugs metabolized by the liver. However, as 362 
far as we know, there were no reports of drug-drug interactions between sage tea and 363 
pharmaceutical drugs or environmental contaminants. In this particular study, where a 364 
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herb-drug interaction was observed, sage tea replaced almost 100% the water that the 365 
animal consumed, since food is provided as dry pellets. Therefore, by taking 1 or 2 cups 366 
of sage tea, a person never reaches the dose of sage extract ingested by mice in this 367 
study. So, it seems that the moderate, traditional drinking of sage tea by people most 368 
likely does not result in adverse interactions with other drugs.  It should, however, be 369 
kept in mind that, if a phytomedicine with a higher dose of sage is taken over an 370 
extended period of time, an opportunity for enzyme induction could occur and 371 
undesirable interactions take place. Additionally, interindividual differences in drug 372 
metabolism, for example due to genetic polymorphism of CYP genes (Tamasi et al., 373 
2003; Wu and Cederbaum, 2005), could increase the susceptibility of different 374 
populations or individuals for herb-drug interactions. 375 
Many of these drug-metabolizing enzymes and also antioxidant enzymes are 376 
known to be gender dependent (Chaubey et al., 1994; Clewell et al., 2002; Sverko et al., 377 
2004), which may ultimately differentially affect the toxicity of drugs between male and 378 
female individuals of the same specie (Kato and Yamazoe, 1992; Meibohm et al., 2002; 379 
Chanas et al., 2003). The hepatotoxicity of CCl4 to females was higher than to males in 380 
both drinking groups. Looking to all measured parameters, several gender differences 381 
were observed which can explain the higher toxicity to female mice. In terms of drug 382 
bioactivation, although the activity of CYP 2E1 was lower in females, the expression of 383 
CYP 2E1, the activity of CYP 2B family and the activity of CYPR were higher in 384 
females which seems to indicate an increased ability to metabolise CCl4 in females. In 385 
terms of cell defences against drug-induced injury, although GPox activity was higher 386 
in females, GST activity is significantly higher in males. At least during the initial stage 387 
of CCl4-induced hepatotoxicity, GST is more likely to confer protection, since CCl4 388 
toxicity is mediated by strong free radicals. 389 
18 
These CYP modulatory as well as antioxidant effects of plant extracts have often 390 
been attributed to phenolic and monoterpenic compounds (Elegbede et al., 1993; 391 
Banerjee et al., 1995; Birt et al., 2001; Ren et al., 2003; Ferguson et al., 2004). 392 
Flavonoids are a diverse group of polyphenols that are produced by several plants 393 
(Havsteen, 2002). In relation to phase I and phase II drug-metabolizing enzymes, 394 
flavonoids have been reported to possess several modulatory effects, either inducing or 395 
decreasing the expression of these enzymes and also either as potent inhibitors or 396 
stimulators of enzyme activities, depending on structure, concentration, and assay 397 
conditions (Zhou et al., 2003; Ferguson et al., 2004). Rosmarinic acid is the predominat 398 
phenolic compound in sage tea (Lima et al., 2005). The oral administration of 399 
rosmarinic acid in rats was previously shown not to induce phase I and phase II 400 
enzymes (Debersac et al., 2001), and, therefore, was possibly not the responsible for the 401 
effects observed in our study. Luteolin-7-glucoside, the major flavonoid present in sage 402 
tea, and also monoterpenes present in the essential oil fraction, could, on the other hand, 403 
be good candidates. However, pre-treatment of rats with luteolin-7-glucoside was 404 
recently found to protect significantly against CCl4-induced toxicity, and its effects 405 
attributed to the compound’s antioxidant properties acting as scavenger of reactive 406 
oxygen species (Zheng et al., 2004). Most likely, the sage tea effects observed here were 407 
a result of interactions and synergisms among the different compounds and metabolites 408 
present, which makes it difficult to attribute them to any particular compound or family 409 
of compounds. 410 
In conclusion, the present work showed that sage tea drinking for 14 days 411 
significantly potentiated CCl4-induced hepatic injury in mice, to a higher degree in 412 
females, as a result, at least in part, of an induction of CYP 2E1. In addition, although 413 
sage tea did not have toxic effects of its own and in fact seemed to improve the 414 
19 
antioxidant status of the liver, the observed herb-toxicant interaction may affect the 415 
efficacy and safety of concurrent medical therapy with drugs that are metabolized by 416 
phase I enzymes. 417 
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Results (tables) 
Table 1 – Effect of sage tea drinking for 14 days on CCl4-induced hepatotoxicity as 
observed by liver histological examinations. 
 
0 - absent; + - few; + + - mild; + + + - moderate; + + + + - severe; + + + + + - extremely severe. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  Male  Female Microscopic 
observation 
Drinking 
group  without CCl4 with CCl4  without CCl4 with CCl4 
water  0 + +  0 + + Hepatocyte  dege-
neration (balooning) sage tea  0 + + + +  0 + + + + + 
        
water  0 +  0 + + 
Hepatocyte necrosis 
sage tea  0 + + +  0 + + + + 
        
water  + + + +  + + + + Infiltration of leuko-
cytes (inflammation) sage tea  + + + + +  + + + + + 
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Table 2 – Effects of sage tea drinking (for 14 days) and CCl4 on CYP activities in mice 
liver. 
 
Values are means ± SEM, n=5. Drinking groups of the same gender with the same letter notation are not 
significantly different from each other (P > 0.05). * P< 0.05, significantly different when compared with 
the same treatment group from males. 
CYP 1A1/2, CYP 2B1/2, CYP 2E1, and CYPR represents EROD, PROD, PNP-H and CYP reductase 
activities, respectively. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  Male  Female 
Enzyme Drinking group  without CCl4 with CCl4  without CCl4 with CCl4 
water  52.8 ± 3.1 a 39.3 ± 3.4 b  46.9 ± 4.8 a 33.1 ± 2.2 b CYP 1A 
(pmol/min/mg) sage tea  58.8 ± 2.4 a 27.5 ± 1.4 c  53.0 ± 3.1 a 19.5 ± 3.2 c 
        
water    8.6 ± 0.7 a   7.7 ± 0.6 a  15.4 ± 2.9 a *   9.5 ± 0.9 b CYP 2B 
(pmol/min/mg) sage tea    9.3 ± 0.8 a   5.1 ± 0.5 a  14.3 ± 1.3 a *   6.7 ± 1.6 b 
        
water  0.63 ± 0.05 a 0.28 ± 0.04 b  0.51 ± 0.06 a * 0.26 ± 0.03 b CYP 2E1 
(pmol/min/mg) sage tea  0.68 ± 0.02 a 0.16 ± 0.02 c  0.57 ± 0.04 a * 0.08 ± 0.03 c 
        
water  15.2 ± 0.7 a 13.4 ± 0.3 b  19.1 ± 0.5 a * 17.8 ± 0.7 a * CYPR 
(mU/mg) sage tea  15.8 ± 0.6 a 10.2 ± 0.5 c  23.2 ± 0.5 b * 12.2 ± 0.6 c * 
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Table 3 – Effects of sage tea drinking (for 14 days) and CCl4 on glutathione-related 
enzymes, glutathione levels and soluble protein in mice livers. 
 
1 Liver soluble proteins measured in the supernatant after a centrifugation of 10,000 × g for 10 min at 4 ºC 
by the Bradford reagent using bovine serum albumin as a standard. 
Values are means ± SEM, n=5. Drinking groups of the same gender with the same letter notation are not 
significantly different from each other (P > 0.05). * P< 0.05, significantly different when compared with 
the same treatment group from males. 
GST: glutathione-s-transferase; GPox: glutathione peroxidase; GR: glutathione reductase; GSH: 
glutathione (reduced form); GSSG: glutathione: oxidized form. 
 
 
 
 
 
 
 
 
 
 
 
  Male  Female 
Parameter Drinking group  without CCl4 with CCl4  without CCl4 with CCl4 
water    305 ± 15 a    307 ± 12 a     128 ± 5 a *    115 ± 6 a * GST 
(mU/mg) sage tea    369 ± 30 b    237 ± 23 c     144 ± 4 a *      76 ± 8 b * 
        
water    432 ± 20 a    456 ± 14 a     779 ± 12 a *    772 ± 12 a * GPox 
(mU/mg) sage tea    493 ± 30 a    570 ± 25 b     888 ± 19 b *    694 ± 25 c * 
        
water    24.1 ± 0.9 a   24.0 ± 0.3 a    20.1 ± 0.6 a,b *   21.1 ± 0.2 a * GR 
(mU/mg) sage tea    25.2 ± 1.0 a   20.9 ± 1.1 b    22.4 ± 0.4 a *   18.3 ± 0.5 b * 
        
water  7.61 ± 0.24 a 7.48 ± 0.22 a  7.46 ± 0.33 a 8.36 ± 0.16 a GSH                 
(nmol/mg liver) sage tea  6.53 ± 0.34 a 8.18 ± 0.56 a  6.71 ± 0.14 a 4.53 ± 1.09 b * 
        
water  0.26 ± 0.02 a,b 0.23 ± 0.02 a,b  0.19 ± 0.02 a 0.27 ± 0.06 a GSSG                
(nmol/mg liver) sage tea  0.19 ± 0.02 b 0.31 ± 0.03 a  0.22 ± 0.03 a 1.35 ± 0.20 b * 
        
water  195.7 ± 4.3 a 200.4 ± 2.8 a  194.1 ± 3.6 a  180.1 ± 1.2 b * Protein 
(mg protein/g liver)1 sage tea  215.8 ± 4.3 b 171.7 ± 4.2 c  214.3 ± 2.9 c 154.8 ± 4.9 d * 
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Results (figures) 
Fig. 1 – Effects of sage tea drinking for 14 days on CCl4-induced increase in plasma 
transaminase activities. (A) ALT: alanine aminotransferase; (B) AST: aspartate 
aminotransferase. Values are means ± SEM, n=5.  For statistical evaluation, these data 
were natural logarithm transformed in order to stabilize the variance. Drinking groups 
of the same gender with the same letter notation are not significantly different from 
each other (P > 0.05). * P< 0.05, significantly different when compared with the same 
treatment group from males.  
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Fig. 2 – Effects of sage tea drinking (for 14 days) and CCl4 on expression of CYP 2E1 
in the liver of male and female mice. Each gel lane was loaded with fifteen µg of 
microsome proteins for the Western blotting analysis. (A) Results obtained from five 
mice of each group. Mean ± SEM. Groups of the same gender with the same letter 
notation are not significantly different from each other (P > 0.05). * P< 0.05, 
significantly different when compared with the same treatment group from males. (B) 
Representative images of the imunodetection of CYP 2E1 by Western Blot from 2 
animals for each group. 
 
